Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · June 16, 2024

Efficacy of Tapinarof Cream 1% Once Daily in Patients With Moderate to Severe Atopic Dermatitis Aged 2 Years and Older

Journal of the American Academy of Dermatology


Additional Info

Journal of the American Academy of Dermatology
Tapinarof Cream 1% Once Daily: Significant Efficacy in the Treatment of Moderate to Severe Atopic Dermatitis in Adults and Children Down to 2 Years of Age in the Pivotal Phase 3 ADORING Trials
J Am Acad Dermatol 2024 May 20;[EPub Ahead of Print], JI Silverberg, LF Eichenfield, AA Hebert, EL Simpson, L Stein Gold, R Bissonnette, KA Papp, J Browning, P Kwong, NJ Korman, PM Brown, DS Rubenstein, SC Piscitelli, MC Somerville, AM Tallman, L Kircik

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading